[go: up one dir, main page]

PE100198A1 - Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos - Google Patents

Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos

Info

Publication number
PE100198A1
PE100198A1 PE1997000760A PE00076097A PE100198A1 PE 100198 A1 PE100198 A1 PE 100198A1 PE 1997000760 A PE1997000760 A PE 1997000760A PE 00076097 A PE00076097 A PE 00076097A PE 100198 A1 PE100198 A1 PE 100198A1
Authority
PE
Peru
Prior art keywords
chlorofluorocarbes
approximately
aerosol formulations
ethanol
momethasone furoate
Prior art date
Application number
PE1997000760A
Other languages
English (en)
Inventor
Joel A Sequeira
Julianne Berry
Imtiaz A Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE100198A1 publication Critical patent/PE100198A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA FORMULACION DE AEROSOL EN SUSPENSION QUE COMPRENDE 1,1,1,2,3,3,3-HEPTAFLUOROPROPANO, DE APROXIMADAMENTE 1% A 10% POR PESO DE ETANOL, Y FUROATO DE MOMETASONA MICRONIZADO EN CONCENTRACIONES DE POR LO MENOS APROXIMADAMENTE 1% DE LA CONCENTRACION DE ETANOL, FORMULACION QUE OPTATIVAMENTE CONTIENE ADEMAS UN SURFACTANTE QUE PUEDE SER ACIDO OLEICO, DICHA FORMULACION DE AEROSOL ESTA CONTENIDA EN UN NEBULIZADOR DE DOSIS MEDIDA QUE DISPENSA UNA CANTIDAD REGULADA DE APROXIMADAMENTE 10 MICROGRAMOS A APROXIMADAMENTE 500 MICROGRAMOS DE FUROATO DE MOMETASONA CON UNA SOLA OPERACION DE ACCIONAMIENTO
PE1997000760A 1996-08-29 1997-08-26 Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos PE100198A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29

Publications (1)

Publication Number Publication Date
PE100198A1 true PE100198A1 (es) 1999-01-11

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000760A PE100198A1 (es) 1996-08-29 1997-08-26 Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos

Country Status (30)

Country Link
EP (1) EP0927037B1 (es)
JP (1) JP3264496B2 (es)
KR (1) KR100316358B1 (es)
CN (1) CN1162157C (es)
AR (1) AR008309A1 (es)
AT (1) ATE202936T1 (es)
AU (1) AU719079B2 (es)
BR (1) BR9711445A (es)
CA (1) CA2263905C (es)
CO (1) CO4900027A1 (es)
CZ (1) CZ294064B6 (es)
DE (1) DE69705628T2 (es)
DK (1) DK0927037T3 (es)
ES (1) ES2159148T3 (es)
GR (1) GR3036674T3 (es)
HU (1) HU227915B1 (es)
ID (1) ID18137A (es)
IL (1) IL128714A (es)
MY (1) MY117377A (es)
NO (1) NO322528B1 (es)
NZ (1) NZ334112A (es)
PE (1) PE100198A1 (es)
PL (1) PL189036B1 (es)
PT (1) PT927037E (es)
SA (1) SA97180339B1 (es)
SK (1) SK282147B6 (es)
TR (1) TR199900379T2 (es)
TW (1) TW475901B (es)
WO (1) WO1998008519A1 (es)
ZA (1) ZA977668B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
JP2005536538A (ja) * 2002-08-23 2005-12-02 シェーリング　コーポレイション 薬学的組成物
MXPA05002248A (es) * 2002-08-27 2005-06-08 Schering Corp Procedimiento para producir formulaciones de inhalador de dosis medida.
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
KR20060106823A (ko) * 2003-10-20 2006-10-12 쉐링 코포레이션 약제학적 에어로졸 조성물
EP2117504A1 (en) * 2007-02-09 2009-11-18 Schering Corporation Stable pharmaceutical drug aerosols
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
SK140493A3 (en) * 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
ATE226067T1 (de) * 1991-06-10 2002-11-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
NO990956L (no) 1999-04-28
CA2263905A1 (en) 1998-03-05
WO1998008519A1 (en) 1998-03-05
ES2159148T3 (es) 2001-09-16
CO4900027A1 (es) 2000-03-27
EP0927037B1 (en) 2001-07-11
TR199900379T2 (xx) 1999-05-21
HK1018206A1 (en) 1999-12-17
PT927037E (pt) 2001-10-31
CN1233960A (zh) 1999-11-03
JP2000503673A (ja) 2000-03-28
AR008309A1 (es) 1999-12-29
AU719079B2 (en) 2000-05-04
HUP9902675A3 (en) 2000-02-28
MY117377A (en) 2004-06-30
CA2263905C (en) 2002-05-14
BR9711445A (pt) 1999-08-24
EP0927037A1 (en) 1999-07-07
DE69705628D1 (de) 2001-08-16
HU227915B1 (en) 2012-05-29
DE69705628T2 (de) 2002-05-08
CN1162157C (zh) 2004-08-18
SK282147B6 (sk) 2001-11-06
NO990956D0 (no) 1999-02-26
CZ63299A3 (cs) 1999-07-14
HUP9902675A2 (hu) 2000-01-28
TW475901B (en) 2002-02-11
IL128714A0 (en) 2000-01-31
JP3264496B2 (ja) 2002-03-11
PL331828A1 (en) 1999-08-02
GR3036674T3 (en) 2001-12-31
CZ294064B6 (cs) 2004-09-15
ZA977668B (en) 1998-02-26
NZ334112A (en) 2000-07-28
KR100316358B1 (ko) 2001-12-12
NO322528B1 (no) 2006-10-16
ATE202936T1 (de) 2001-07-15
AU4232997A (en) 1998-03-19
IL128714A (en) 2003-05-29
DK0927037T3 (da) 2001-09-24
SK25399A3 (en) 1999-12-10
SA97180339B1 (ar) 2006-01-31
ID18137A (id) 1998-03-05
PL189036B1 (pl) 2005-06-30
KR20000035879A (ko) 2000-06-26

Similar Documents

Publication Publication Date Title
PE100198A1 (es) Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos
US5461068A (en) Imidazole derivative tincture and method of manufacture
DK0656207T4 (da) Aerosolformuleringer uden chlorfluorcarbonforbindelser
ES2176355T3 (es) Formulaciones de aerosol de peptidos y proteinas.
ES2112988T3 (es) Formulaciones de aerosol que contienen dipropionato de beclometasona sin agentes tensioactivos.
DE69808463D1 (de) Selbstemulgierende formulierung enthaltend saure lipophile verbindungen
ES2031467T3 (es) Formulaciones acuosas de esteroides apropiadas para administracion por via nasal.
ES2079210T3 (es) Formulacion farmaceutica de aerosol.
DE68917884D1 (de) Phosphinsäure-Derivate von Steroiden als 5-alpha-Reduktase-Inhibitoren.
DE69928665D1 (de) Wässrige zusammenstellungen die corticosteroide enthalten zur nasalen oder pulmonalen verabreichung
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
AR009231A1 (es) Formulaciones en aerosol de formoterol.
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
DE68917885D1 (de) Phosphonsäure-Derivate von Steroiden als Hemmstoffe der 5-alpha-Reduktase.
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
DK0647129T3 (da) Præparat til topisk anvendelse
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
ECSP972240A (es) Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos
JPS55136228A (en) Novel antiallergic agent
SE8704712L (sv) Norfenefrininnehallande, farmaceutiska kompositioner

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term